Details of Orthocell’s upcoming launch on the ASX has been featured in the Australian Financial Review (AFR).
Orthocell to list on ASX
Orthocell’s plans to list on the Australian Stock Exchange (ASX) have been featured in The Australian newspaper.Â
Stem cells show promise mending busted tendons
Jill Margo, Health Editor at the Australian Financial Review, has published a feature article on Orthocell’s innovative autologous tenocyte implantation (ATI) therapy.